Emergent Biosolutions (NY: EBS )
65.90
USD
+0.68
(+1.04%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 30, 2021
Add to My Watchlist
All news about Emergent Biosolutions
From Motley Fool
Emergent BioSolutions Stock Higher As COVID-19 Vaccine Production To Resume At Baltimore Plant
July 29, 2021
From Benzinga
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
From Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
From Motley Fool
From Benzinga
From Motley Fool
A Look Into Healthcare Sector Value Stocks
June 28, 2021
From Benzinga
Faruqi & Faruqi, LLP is Investigating Emergent BioSolutions (EBS) on Behalf of its Shareholders
June 23, 2021
From NewMediaWire
5 Value Stocks To Watch In The Healthcare Sector
June 21, 2021
From Benzinga
From PR Newswire
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.